What is CallaDerm?
Based in Kingsport, Tennessee, and led by Dr. Jami Reaves, CallaDerm operates as a comprehensive dermatologic practice. The firm distinguishes itself through a robust service portfolio that addresses critical skin health needs, including the treatment of skin cancer, psoriasis, and sun damage. Beyond traditional clinical interventions, CallaDerm integrates modern digital health solutions, such as telemedicine and a dedicated patient portal, to enhance accessibility and patient engagement. The practice maintains a strong focus on patient education, empowering individuals to manage their skin health proactively while maintaining a commitment to personalized, timely care for a diverse patient base.
How much funding has CallaDerm raised?
CallaDerm has raised a total of $331K across 2 funding rounds:
Debt
$150K
Debt
$181K
Debt (2020): $150K with participation from PPP
Debt (2021): $181K led by PPP
Key Investors in CallaDerm
PPP
Public-Private Partnership
What's next for CallaDerm?
With the successful acquisition of this recent capital, CallaDerm is poised to enter a new phase of organizational maturity. The strategic deployment of these funds will likely focus on scaling clinical operations and enhancing the technological backbone of their patient-centric model. As the healthcare sector continues to shift toward hybrid care delivery, CallaDerm's investment in telemedicine and digital infrastructure provides a competitive advantage. Future growth will likely involve expanding the reach of their specialized dermatologic treatments, potentially increasing market penetration in the regional healthcare ecosystem while maintaining the high standards of care that define their current practice.
See full CallaDerm company page
